Legend Biotech (LEGN) Construction in Progress (2019 - 2020)
Legend Biotech (LEGN) posted Construction in Progress of $33.6 million for Q4 2020, up 1082.74% on a QoQ basis from $2.8 million in Q4 2019, and up 1082.74% year-over-year from $2.8 million in Q1 2020.
Legend Biotech (LEGN) has 2 years of Construction in Progress data on file, last reported at $33.6 million in Q4 2020.
- In Q4 2020, Construction in Progress rose 1082.74% year-over-year to $33.6 million; the TTM figure through Dec 2020 stood at $33.6 million (up 1082.74% YoY), while the FY2020 annual figure was $33.6 million, up 1082.74% from the prior year.
- Construction in Progress climbed to $33.6 million in Q4 2020, from $2.8 million in the prior quarter.
- Across five years, Construction in Progress topped out at $33.6 million in Q4 2020 and bottomed at $2.8 million in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 33.64 Mn |
| Dec 31, 2019 | 2.84 Mn |